Company Filing History:
Years Active: 2012
Title: Esther Masih-Khan: Innovator in Gene Therapy
Introduction
Esther Masih-Khan is a prominent inventor based in California, known for her significant contributions to the field of gene therapy. She has developed innovative methods that enhance the understanding of gene transcription and patient treatment monitoring.
Latest Patents
Esther holds a patent titled "Effects of inhibitors of FGFR3 on gene transcription." This patent focuses on methods of utilizing biomarkers to identify patients for treatment or to monitor their response to treatment. The invention teaches how alterations in levels of gene expression of the biomarkers, particularly in response to FGFR3 inhibition, can be measured, allowing for necessary identifications or adjustments to be made accordingly. She has 1 patent to her name.
Career Highlights
Esther is currently employed at Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to collaborate with other experts in the field, further advancing her research and innovations.
Collaborations
Esther has worked alongside notable colleagues, including Carla C. Heise and Edward Moler. Their collaborative efforts have contributed to the success of her research and the development of her patent.
Conclusion
Esther Masih-Khan is a trailblazer in the field of gene therapy, with her innovative patent paving the way for improved patient treatment strategies. Her work continues to impact the medical community positively.